|
Having trouble viewing this email? View it as a Web page.
New Study Finds No Safety Concerns in HPV Vaccine During Pregnancy
|
A new CDC study looking at human papillomavirus (HPV) vaccination during pregnancy was published in the journal Vaccine this week.
|
 |
Researchers reviewed reports to the Vaccine Adverse Event Reporting System (VAERS) about women who received the HPV vaccine Gardasil® while they were pregnant. Gardasil® is not currently recommended for pregnant women, given the limited available safety data in pregnancy. However, because catchup vaccination is recommended for women through age 26, there is a possibility that some women will receive the vaccine before realizing that they are pregnant. This study found no patterns of safety concerns for pregnant woman who received Gardasil®, or for their babies.
|
|
This study adds to the literature on the safety of HPV vaccination during pregnancy. Gardasil®’s manufacturer, Merck, maintained a Gardasil® Pregnancy Registry from 2006 to 2012. No safety concerns were noted in this registry.
For more information on HPV vaccine safety, see: http://www.cdc.gov/vaccinesafety/Vaccines/HPV/Index.html
|
| This email was sent to list-cdc@xxxxxxxxxxx using GovDelivery,on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30329-4027 • 1-800-CDC-INFO (800-232-4636) |
 |
|
